|
|
|
Screaming to be Heard: Hormonal Connections Women Suspect, and Doctors Still Ignore, Revised and Updated
|
|
Are Your Hormones Making You Sick?: A Woman's Guide To Better Health Through Hormonal Balance
In this book, the Taylors combine their knowledge of the mind and body to address illnesses that have plagued women in the United States for many years. Hysterectomies are one of the most common surgical procedures performed in U.S. hospitals. Breast cancer is the leading cause of death in women less than 50 years old. Depression and anxiety are commonplace. By reading this book you will learn: What creates hormone imbalances in the body. How hormonal imbalances cause weight gain and acne. What is the best laboratory test for diagnosing hormonal problems. What causes PMS, perimenopausal and menopausal symptoms. How hormonal imbalances effect your sex drive, energy levels and mood. What can you do to stop hot flashes. How to limit your risk factors for breast cancer, fibroids and osteoporosis. How to make dietary and lifestyle choices which can prevent and treat hormonal imbalances. How to correct hormonal imbalances by using conventional medical treatments and natural therapies..
Price: $9.87
[Notify me when price goes down.]
|
|
Hot Flashes: 21 Non-Hormonal Strategies to Put Out the Fire
|
|
The 2007-2012 Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents in Japan
This study covers the latent demand outlook for non-hormonal anti-arthritics and anti-inflammatory agents across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for non-hormonal anti-arthritics and anti-inflammatory agents. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved..
Price: $495.00
[ Notify me when price goes down.]
|
|
The 2006-2011 World Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents
WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for non-hormonal anti-arthritics and anti-inflammatory agents is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either lower or higher than actual sales if a market is inefficient (i.e., not representative of relatively competitive levels). Inefficiencies arise from a number of factors, including the lack of international openness, cultural barriers to consumption, regulations, and cartel-like behavior on the part of firms. In general, however, latent demand is typically larger than actual sales in a country market. For reasons discussed later, this report does not consider the notion of “unit quantities”, only total latent revenues (i.e., a calculation of price times quantity is never made, though one is implied). The units used in.
Price: $795.00
[ Notify me when price goes down.]
|
|
Endocrine and Hormonal Toxicology
Endocrine and Hormonal Toxicology Edited by Philip W. Harvey, Kevin C. Rush and Andrew Cockburn AgrEvo UK Ltd, Saffron Walden, UK This is the first book to consider the integrated role of the classical endocrine system and hormones (including those from tissues outside the classical endocrine system) in toxicological responses. Although focusing on the latest knowledge on endocrine glands as target organs and the mechanistic and molecular basis for toxicity in these organs, Endocrine and Hormonal Toxicology has been written to cover toxicological responses at the whole body level mediated by endocrine or hormonal mechanisms. This whole body, multi-organ approach significantly broadens the relevance of this volume to toxicologists. Following an introductory section on the types of endocrine toxicity including primary, secondary and indirect mechanisms, the next section deals with endocrine organs as toxicological targets. International contributions focus on the pituitary, thyroid and parathyroids, adrenals, testes, ovaries and the pancreas, and comparative endocrine carcinogenesis. A third section of the book develops the whole body approach, in which chapters are devoted to hormonal mechanisms of toxicity to the immune, nervous, cardiovascular, gastrointestinal and reproductive systems, as well as to the liver, kidney and skin. The final section covers human and environmental health perspectives discussing endocrine disrupting chemicals, hormonal mechanisms in breast cancer and current regulatory trends in endocrine and hormonal toxicology. The comprehensive nature of Endocrine and Hormonal Toxicology makes it accessible to both specialist and general toxicologists, and to those within the fields of endocrinology, pharmacology and pathology..
Price: $328.00
[ Notify me when price goes down.]
|
|
Peptides and Non Peptides of Oncology and Neuroendocrine Relevance: From Basic to Clinical Research
The book describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Price: $94.00
[ Notify me when price goes down.]
|
|
The 2007-2012 World Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents
This study covers the world outlook for non-hormonal anti-arthritics and anti-inflammatory agents across more than 200 countries For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved..
Price: $795.00
[ Notify me when price goes down.]
|
|
The 2007-2012 Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents in Greater China
This study covers the latent demand outlook for non-hormonal anti-arthritics and anti-inflammatory agents across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of “economic population”, as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this “economic” definition of population, comparative benchmarks allow the reader to quickly gauge a city’s marketing and distribution value vis-à-vis others. This exercise is quite useful for persons setting up distribution centers or sales force strategies. Using econometric models which project fundamental economic dynamics within each region and city of influence, latent demand estimates are created for non-hormonal anti-arthritics and anti-inflammatory agents. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved..
Price: $495.00
[ Notify me when price goes down.]
|
|
|
|
|